Table 4.
Comparison of baseline clinical data between Group A and Group B
| Group A (n = 40) | Group B (n = 36) | t/χ2 value | P value | |
| Gender (Male) | 29 | 26 | 0.001 | 0.978 |
| Age (yr) | 62.82 ± 12.93 | 64.82 ± 11.82 | 0.722 | 0.472 |
| Tumor size (cm) | 3.75 ± 1.21 | 3.13 ± 0.82 | 2.683 | 0.009 |
| Number of tumors | 0.002 | 0.961 | ||
| Single | 22 | |||
| 2-3 | 18 | 16 | ||
| Child-Pugh classification | 0.023 | 0.878 | ||
| A | 26 | 24 | ||
| B | 14 | 12 | ||
| TBiL (μmol/L) | 18.28 ± 5.28 | 17.38 ± 5.62 | 0.738 | 0.463 |
| AFP (ng/ml) | 612.29 ± 127.38 | 567.28 ± 92.39 | 1.746 | 0.085 |
| ALB (g/L) | 37.19 ± 5.39 | 34.94 ± 4.53 | 1.958 | 0.054 |
| ALT (U/L) | 35.27 ± 15.14 | 36.49 ± 12.31 | 0.383 | 0.703 |
| AST (U/L) | 38.63 ± 15.13 | 36.22 ± 13.26 | 0.735 | 0.465 |
AFP: Alpha-fetoprotein; ALB: Serum albumin; ALT: Aminotransferase; AST: Aspartate aminotransferase; TBiL: Total bilirubin.